Max Herzberg

About

Portfolio · 1

VBL Therapeutics

Targeted Therapies for Immune-inflammatory Diseases

1 round $40.0M committed Latest: 2010-10

Investment activity

1 portfolio exit on record.

Q&A

What is Max Herzberg's primary investment focus?

Max Herzberg primarily invests in biotech companies, specializing in the Health Tech & Life Sciences sector.

Can you name a notable exit for Max Herzberg?

Max Herzberg had an exit with VBL Therapeutics, which went public on NASDAQ in October 2014 with a valuation of $120M.

Which company is a key part of Max Herzberg's portfolio?

A key company in Max Herzberg's portfolio is VBL Therapeutics, a B2B company founded in 2000 that focuses on targeted therapies for immune-inflammatory diseases.

What is the total capital raised by VBL Therapeutics, a company in Max Herzberg's portfolio?

VBL Therapeutics, a portfolio company of Max Herzberg, has raised $109.77M in total funding.

When did Max Herzberg make a notable investment?

Max Herzberg made a notable investment in October 2010, which also marked the addition of a new portfolio company.